Glycogen synthase kinase 3 alpha phosphorylates and regulates the osteogenic activity of Osterix

Biochemical and Biophysical Research Communications

Volumn 434, Issue 3, 2013, Pages 653-658

  Li, Hongyan ^a   Jeong, Hyung Min ^a   Choi, You Hee ^a   Lee, Sung Ho ^a   Jeong, Hye Gwang ^b   Jeong, Tae Cheon ^c   Lee, Kwang Youl ^a  

^a Chonnam National University   (South Korea)

^b Chungnam National University   (South Korea)

^c Yeungnam University   (South Korea)

Author keywords

Glycogen synthase kinase 3 alpha; Osteoblast differentiation; Osterix; Protein stability; Transcriptional activity

Indexed keywords

GLYCOGEN SYNTHASE KINASE 3ALPHA; PROTEIN SERINE THREONINE KINASE; REGULATOR PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR OSTERIX; WNT PROTEIN; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 ALPHA; LUCIFERASE; OSTERIX PROTEIN, MOUSE;

ANIMAL CELL; ARTICLE; BONE DEVELOPMENT; CELL DIFFERENTIATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; UPREGULATION; ANIMAL; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; REPORTER GENE; SITE DIRECTED MUTAGENESIS;

ANIMALS; GENES, REPORTER; GLYCOGEN SYNTHASE KINASE 3; LUCIFERASES; MICE; MUTAGENESIS, SITE-DIRECTED; PHOSPHORYLATION; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

MLCS; MLOWN;

EID: 84880500842     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.03.137     Document Type: Article

References (27)

1. F. Zhu, M.S. Friedman, W. Luo, P. Woolf, K.D. Hankenson, The transcription factor osterix (SP7) regulates BMP6-induced human osteoblast differentiation, J. Cell Physiol. 227 (2012) 2677-2685.
2. W. Yun-Feng, N. Matsuo, H. Sumiyoshi, H. Yoshioka, Sp7/Osterix up-regulates the mouse pro-alpha3(V) collagen gene (Col5a3) during the osteoblast differentiation, Biochem. Biophys. Res. Commun. 394 (2010) 503-508.
3. K. Nakashima, X. Zhou, G. Kunkel, Z. Zhang, J.M. Deng, R.R. Behringer, B. de Crombrugghe, The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation, Cell 108 (2002) 17-29.
4. J. Zhu, E. Shimizu, X. Zhang, N.C. Partridge, L. Qin, EGFR signaling suppresses osteoblast differentiation and inhibits expression of master osteoblastic transcription factors Runx2 and Osterix, J. Cell Biochem. 112 (2011) 1749-1760.
5. W.F. Leong, T. Zhou, G.L. Lim, B. Li, Protein palmitoylation regulates osteoblast differentiation through BMP-induced Osterix expression, PLoS One 4 (2009) e4135.
6. S.H. Hong, X. Lu, M.S. Nanes, J. Mitchell, Regulation of osterix (Osx, Sp7) and the Osx promoter by parathyroid hormone in osteoblasts, J. Mol. Endocrinol. 43 (2009) 197-207.
7. C. Zhang, K. Cho, Y. Huang, J.P. Lyons, X. Zhou, K. Sinha, P.D. McCrea, B. de Crombrugghe, Inhibition of Wnt signaling by the osteoblast-specific transcription factor Osterix, Proc. Natl. Acad. Sci. USA 105 (2008) 6936-6941.
8. Y. Cao, Z. Zhou, B. de Crombrugghe, K. Nakashima, H. Guan, X. Duan, S.F. Jia, E.S. Kleinerman, Osterix, a transcription factor for osteoblast differentiation, mediates antitumor activity in murine osteosarcoma, Cancer Res. 65 (2005) 1124-1128.
9. A.B. Celil, P.G. Campbell, BMP-2 and insulin-like growth factor-I mediate Osterix (Osx) expression in human mesenchymal stem cells via the MAPK and protein kinase D signaling pathways, J. Biol. Chem. 280 (2005) 31353-31359.
10. H. Zebger-Gong, D. Muller, M. Diercke, D. Haffner, B. Hocher, S. Verberckmoes, S. Schmidt, P.C. D'Haese, U. Querfeld, 1,25-Dihydroxyvitamin D3-induced aortic calcifications in experimental uremia: up-regulation of osteoblast markers, calcium-transporting proteins and osterix, J. Hypertens. 29 (2011) 339-348.
11. X. Lu, L. Gilbert, X. He, J. Rubin, M.S. Nanes, Transcriptional regulation of the osterix (Osx, Sp7) promoter by tumor necrosis factor identifies disparate effects of mitogen-activated protein kinase and NF kappa B pathways, J. Biol. Chem. 281 (2006) 6297-6306.
12. G.P. Zambetti, E.M. Horwitz, E. Schipani, Skeletons in the p53 tumor suppressor closet: genetic evidence that p53 blocks bone differentiation and development, J. Cell Biol. 172 (2006) 795-797.
13. X. Wang, C.H. Goh, B. Li, P38 mitogen-activated protein kinase regulates osteoblast differentiation through osterix, Endocrinology 148 (2007) 1629-1637.
14. Y.H. Choi, H.M. Jeong, Y.H. Jin, H. Li, C.Y. Yeo, K.Y. Lee, Akt phosphorylates and regulates the osteogenic activity of Osterix, Biochem. Biophys. Res. Commun. 411 (2011) 637-641.
15. Y.H. Choi, Y.M. Gu, J.W. Oh, K.Y. Lee, Osterix is regulated by Erk1/2 during osteoblast differentiation, Biochem. Biophys. Res. Commun. 415 (2011) 472-478.
16. R.S. Jope, C.J. Yuskaitis, E. Beurel, Glycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeutics, Neurochem. Res. 32 (2007) 577-595.
17. A. Ali, K.P. Hoeflich, J.R. Woodgett, Glycogen synthase kinase-3: properties, functions, and regulation, Chem. Rev. 101 (2001) 2527-2540.
18. F. Hernandez, E.G. de Barreda, A. Fuster-Matanzo, P. Goni-Oliver, J.J. Lucas, J. Avila, The role of GSK3 in Alzheimer disease, Brain Res. Bull. 80 (2009) 248-250.
19. C. Gao, C. Holscher, Y. Liu, L. Li, GSK3: a key target for the development of novel treatments for type 2 diabetes mellitus and Alzheimer disease, Rev. Neurosci. 23 (2012) 1-11.
20. A.K. Farina, Y.S. Bong, C.M. Feltes, S.W. Byers, Post-transcriptional regulation of cadherin-11 expression by GSK-3 and beta-catenin in prostate and breast cancer cells, PLoS One 4 (2009) e4797.
21. S. Rokutanda, T. Fujita, N. Kanatani, C.A. Yoshida, H. Komori, W. Liu, A. Mizuno, T. Komori, Akt regulates skeletal development through GSK3, mTOR, and FoxOs, Dev. Biol. 328 (2009) 78-93.
22. R.M. Kapadia, A.R. Guntur, M.I. Reinhold, M.C. Naski, Glycogen synthase kinase 3 controls endochondral bone development: contribution of fibroblast growth factor 18, Dev. Biol. 285 (2005) 496-507.
23. R. Labugger, L. Organ, C. Collier, D. Atar, J.E. Van Eyk, Extensive troponin I and T modification detected in serum from patients with acute myocardial infarction, Circulation 102 (2000) 1221-1226.
24. Q.M. Wang, P.J. Roach, C.J. Fiol, Use of a synthetic peptide as a selective substrate for glycogen synthase kinase 3, Anal. Biochem. 220 (1994) 397-402.
25. C. Yost, M. Torres, J.R. Miller, E. Huang, D. Kimelman, R.T. Moon, The axis-inducing activity, stability, and subcellular distribution of beta-catenin is regulated in Xenopus embryos by glycogen synthase kinase 3, Genes Dev. 10 (1996) 1443-1454.
26. D.D. Williams, O. Marin, L.A. Pinna, C.G. Proud, Phosphorylated seryl and threonyl, but not tyrosyl, residues are efficient specificity determinants for GSK-3beta and Shaggy, FEBS Lett. 448 (1999) 86-90.
27. F. Hernandez, E. Langa, R. Cuadros, J. Avila, N. Villanueva, Regulation of GSK3 isoforms by phosphatases PP1 and PP2A, Mol. Cell Biochem. 344 (2010) 211-215.